Kyverna Therapeutics, Inc. (KYTX) Ownership

$2.81

$0.02 (-0.53%)
Last update: 01:00 PM EST
Day's range
$2.76
Day's range
$2.97

Kyverna Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIDA VENTURES ADVISORS, LLC 04/03/2025 4.52 M $8.73 B   0.00% 10.47%
GILEAD SCIENCES, INC. 05/13/2025 4.13 M $7.96 M   0.00% 9.55%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2025 3.37 M $6.50 M   0.00% 7.79%
NOVO HOLDINGS A/S 05/15/2025 1.85 M $3.57 M   0.00% 4.28%
BLACKROCK, INC. 05/02/2025 1.68 M $3.24 M   0.23% 3.88%
VANGUARD GROUP INC 05/09/2025 1.30 M $2.51 M   -1.13% 3.00%
CITADEL ADVISORS LLC 05/15/2025 993.62 K $1.92 M   512.14% 2.30%
INSIGHT HOLDINGS GROUP, LLC 05/15/2025 989.05 K $1.91 M   8.34% 2.29%
FRANKLIN RESOURCES INC 05/13/2025 692.03 K $1.34 M   0.00% 1.60%
MBB PUBLIC MARKETS I LLC 05/16/2025 614.48 K $1.19 M   0.00% 1.42%
05/15/2025 586.91 K $1.13 M   0.00% 1.36%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 579.60 K $1.12 M   -2.37% 1.34%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 563.97 K $1.09 M   4.50% 1.31%
04/30/2025 396.22 K $764.71 K   100.00% 0.92%
04/02/2025 376.19 K $726.04 K   0.01% 0.87%
STATE STREET CORP 05/15/2025 374.58 K $722.94 K   -1.40% 0.87%
MILLENNIUM MANAGEMENT LLC 05/15/2025 238.24 K $459.80 K   -68.09% 0.55%
NORTHERN TRUST CORP 05/13/2025 191.66 K $369.91 K   -2.06% 0.44%
SUPERSTRING CAPITAL MANAGEMENT LP 05/15/2025 191.29 K $369.18 K   5.00% 0.44%
UBS GROUP AG 05/13/2025 177.67 K $342.90 K   -12.65% 0.41%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 165.37 K $319.16 K   -2.60% 0.38%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 136.30 K $263.06 K   70.38% 0.32%
MORGAN STANLEY 05/15/2025 134.91 K $260.38 K   -32.74% 0.31%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 124.96 K $241.17 K   179.55% 0.29%
TWO SIGMA INVESTMENTS, LP 05/15/2025 122.98 K $237.35 K   -32.30% 0.28%
GOLDMAN SACHS GROUP INC 06/27/2025 104.46 K $201.61 K   -7.94% 0.24%
TD ASSET MANAGEMENT INC 05/07/2025 90.24 K $174.17 K   0.00% 0.21%
BARCLAYS PLC 05/15/2025 81.39 K $157.00 K   -9.15% 0.19%
TWO SIGMA ADVISERS, LP 05/15/2025 80.90 K $156.14 K   0.76% 0.19%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 71.06 K $137.14 K   100.00% 0.16%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 68.63 K $132.45 K   31.07% 0.16%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2025 67.55 K $130.36 K   54.35% 0.16%
BANK OF NEW YORK MELLON CORP 04/29/2025 48.78 K $94.15 K   22.16% 0.11%
05/12/2025 47.51 K $91.69 K   100.00% 0.11%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 46.38 K $89.52 K   3.11% 0.11%
JPMORGAN CHASE & CO 05/12/2025 39.50 K $76.24 K   -98.18% 0.09%
STIFEL FINANCIAL CORP 05/14/2025 39.16 K $75.59 K   -0.46% 0.09%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 38.60 K $74.50 K   2.14% 0.09%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 37.83 K $73.01 K   -86.22% 0.09%
FEDERATED HERMES, INC. 05/08/2025 36.00 K $69.48 K   12.50% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 34.45 K $66.49 K   174.02% 0.08%
ALPS ADVISORS INC 04/30/2025 32.13 K $62.00 K   -7.98% 0.07%
RHUMBLINE ADVISERS 05/29/2025 31.61 K $61.01 K   21.97% 0.07%
ALLIANCEBERNSTEIN L.P. 05/15/2025 30.01 K $57.92 K   0.00% 0.07%
SEI INVESTMENTS CO 05/14/2025 24.66 K $47.59 K   100.00% 0.06%
MARSHALL WACE, LLP 05/15/2025 24.56 K $47.40 K   61.15% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 21.95 K $42.35 K   100.00% 0.05%
CITIGROUP INC 05/12/2025 19.15 K $36.97 K   -5.77% 0.04%
BANK OF AMERICA CORP /DE/ 05/15/2025 17.33 K $33.44 K   -20.48% 0.04%
WELLS FARGO & COMPANY/MN 05/13/2025 16.68 K $32.19 K   -90.68% 0.04%

Kyverna Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 94 institutional investors and hedge funds held shares of Kyverna Therapeutics, Inc.. The most heavily invested institutionals were:

Vida Ventures Advisors, LLC: 4.52 M

GILEAD SCIENCES, INC.: 4.13 M

Bain Capital Life Sciences Investors, LLC: 3.37 M

Novo Holdings A/S: 1.85 M

BlackRock, Inc.: 1.68 M

VANGUARD GROUP INC: 1.3 M

59.67% of Kyverna Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 29.14 M shares in the last 24 months. This purchase volume represents approximately $81.90 M in transactions.